LPA Gene Coronary artery disease susceptibility to Genetic Test sale cost 4400 AED
SFXN4 Gene Combined oxidative phosphorylation deficiency type 18 Genetic Test sale cost 4400 AED SFXN4 Gene Combined oxidative phosphorylation deficiency type 18 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CTNS Gene Cystinosis nephropathic Genetic Test sale cost 4400 AED CTNS Gene Cystinosis nephropathic Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

LPA Gene Coronary artery disease susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “LPA Gene Coronary Artery Disease Susceptibility Genetic Test” is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to assess an individual’s genetic predisposition to developing coronary artery disease (CAD). This test specifically examines variations in the LPA gene, which have been linked to an increased risk of CAD. The LPA gene encodes for a protein called lipoprotein(a), high levels of which in the blood can lead to the development of plaques in the arteries, thereby increasing the risk of heart attacks and other cardiovascular diseases.

By analyzing a person’s DNA, the test identifies specific mutations or polymorphisms within the LPA gene that are associated with elevated lipoprotein(a) levels and, consequently, a higher risk of coronary artery disease. This information can be invaluable for individuals with a family history of CAD or those who have other risk factors for the disease.

The test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost of the LPA Gene Coronary Artery Disease Susceptibility Genetic Test is 4400 AED. The results from this test can provide individuals with critical insights into their genetic risk for CAD, allowing them to take proactive measures in consultation with healthcare professionals to mitigate this risk through lifestyle changes, medication, or other interventions deemed necessary based on the test findings and overall health assessment.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LPA Gene Coronary Artery Disease Susceptibility to Genetic Test

At DNA Labs UAE, we offer the LPA Gene Coronary Artery Disease Susceptibility Genetic Test at a cost of AED 4400.0. This test helps in assessing an individual’s risk of developing coronary artery disease (CAD) by analyzing the LPA gene.

Test Details

Coronary artery disease (CAD) is a common cardiovascular disorder characterized by the narrowing or blockage of the coronary arteries, which supply oxygen-rich blood to the heart. It is a complex disease caused by a combination of genetic and environmental factors.

The LPA (Lipoprotein(a)) gene codes for a lipoprotein particle in the blood called Lp(a). Elevated levels of Lp(a) have been associated with an increased risk of developing CAD. Lp(a) is believed to contribute to the formation of atherosclerotic plaques in the arteries, leading to the development of CAD.

Our LPA Gene Coronary Artery Disease Susceptibility Genetic Test utilizes NGS (Next-Generation Sequencing) technology. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or the entire genome. This test can analyze the LPA gene and identify variations or mutations that may be associated with an increased susceptibility to CAD.

By undergoing this genetic test, individuals can gain insight into their genetic predisposition to CAD. This information can be useful in assessing their risk of developing the disease and may guide preventive measures or lifestyle modifications to reduce the risk.

It is important to note that genetic testing for CAD susceptibility is just one piece of the puzzle. Lifestyle factors such as diet, exercise, smoking, and managing other cardiovascular risk factors (e.g., hypertension, diabetes) also play a significant role in the development of CAD. Therefore, the results of a genetic test should be interpreted in conjunction with other clinical and lifestyle factors to provide a comprehensive assessment of an individual’s risk for CAD.

Test Components and Price

  • Test Name: LPA Gene Coronary Artery Disease Susceptibility Genetic Test
  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the LPA Gene Coronary Artery Disease Susceptibility Genetic Test, it is recommended to have a clinical history of the patient who is going for the test. Additionally, a genetic counseling session can be conducted to draw a pedigree chart of family members affected with Coronary artery disease, susceptibility to CAD.

At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Contact us today to schedule your LPA Gene Coronary Artery Disease Susceptibility Genetic Test and take a proactive step towards understanding your risk for CAD.

Test Name LPA Gene Coronary artery disease susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for LPA Gene Coronary artery disease, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Coronary artery disease, susceptibility to
Test Details

Coronary artery disease (CAD) is a common cardiovascular disorder characterized by the narrowing or blockage of the coronary arteries, which supply oxygen-rich blood to the heart. It is a complex disease caused by a combination of genetic and environmental factors.

LPA (Lipoprotein(a)) is a gene that codes for a lipoprotein particle in the blood called Lp(a). Elevated levels of Lp(a) have been associated with an increased risk of developing CAD. Lp(a) is believed to contribute to the formation of atherosclerotic plaques in the arteries, leading to the development of CAD.

NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or the entire genome. NGS-based genetic tests can analyze the LPA gene and identify variations or mutations that may be associated with an increased susceptibility to CAD.

By undergoing an NGS genetic test targeting the LPA gene, individuals can gain insight into their genetic predisposition to CAD. This information can be useful in assessing their risk of developing the disease and may guide preventive measures or lifestyle modifications to reduce the risk.

It is important to note that genetic testing for CAD susceptibility is just one piece of the puzzle. Lifestyle factors such as diet, exercise, smoking, and managing other cardiovascular risk factors (e.g., hypertension, diabetes) also play a significant role in the development of CAD. Therefore, the results of a genetic test should be interpreted in conjunction with other clinical and lifestyle factors to provide a comprehensive assessment of an individual’s risk for CAD.

SKU: TEST-2263 Category:

Related products